Inventor · disambiguated record
Aysegul Ozen
Also filed as: OZEN AYSEGUL · ÖZEN AYSEGÜL
3 granted patents·7 pending applications·2 citations·filing 2018–2025
53Inventor score
Top patents by PatentIndex Score
10 records- 0193US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 0280US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 0372US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 0464US2025120961A1P53 modulatorsNESTED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0561US2025289811A1Heterocyclic derivatives as mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0660US2024382483A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 0758US2024299387A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 0858US2024308981A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 0944US2025288571A1Mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1032US11521704B2Method for probing at least one binding site of a proteinUNIV MASSACHUSETTS·Filed 2018·Granted Dec 6, 2022·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Aysegul Ozen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →